These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7894187)

  • 1. The strategy to treat disseminated neuroblastoma utilizing bone marrow transplantation: what is the surgeon's role?
    Yokoyama S; Hirakawa H; Soeda J; Ueno S; Tajima T; Mitomi T; Yabe H; Yabe M; Kato S
    Surg Today; 1994; 24(10):895-9. PubMed ID: 7894187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma.
    Sibley GS; Mundt AJ; Goldman S; Nachman J; Reft C; Weichselbaum RR; Hallahan DE; Johnson L
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1127-35. PubMed ID: 7607934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
    Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK
    J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive treatment of advanced neuroblastoma involving autologous bone marrow transplant.
    Mugishima H; Harada K; Suzuki T; Chin M; Shimada T; Takamura M; Shichino H; Fujisawa T; Ichikawa M; Iwata M
    Acta Paediatr Jpn; 1995 Aug; 37(4):493-9. PubMed ID: 7572151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study.
    Fukuda M; Miyajima Y; Miyashita Y; Horibe K
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):10-3. PubMed ID: 11196262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
    McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
    J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastoma: treatment outcome after incomplete resection of primary tumors.
    Moon SB; Park KW; Jung SE; Youn WJ
    Pediatr Surg Int; 2009 Sep; 25(9):789-93. PubMed ID: 19629500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment combined with bone marrow transplantation for advanced neuroblastoma: an analysis of patients who were pretreated intensively with the protocol of the Study Group of Japan.
    Ohnuma N; Takahashi H; Kaneko M; Uchino J; Takeda T; Iwafuchi M; Ohhira M; Nishihira H; Mugishima H; Yokoyama J
    Med Pediatr Oncol; 1995 Mar; 24(3):181-7. PubMed ID: 7838040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age.
    Philip T; Bernard JL; Zucker JM; Pinkerton R; Lutz P; Bordigoni P; Plouvier E; Robert A; Carton R; Philippe N
    J Clin Oncol; 1987 Feb; 5(2):266-71. PubMed ID: 3543245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete surgical resection combined with aggressive adjuvant chemotherapy and bone marrow transplantation prolongs survival in children with advanced neuroblastoma.
    Chamberlain RS; Quinones R; Dinndorf P; Movassaghi N; Goodstein M; Newman K
    Ann Surg Oncol; 1995 Mar; 2(2):93-100. PubMed ID: 7728576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?
    Philip T; Zucker JM; Bernard JL; Lutz P; Bordigoni P; Plouvier E; Robert A; Roché H; Souillet G; Bouffet E
    J Clin Oncol; 1991 Jun; 9(6):1037-44. PubMed ID: 2033417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
    Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC
    J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sites of relapse in patients with neuroblastoma following bone marrow transplantation in relation to preparatory "debulking" treatments.
    Ikeda H; August CS; Goldwein JW; Ross AJ; D'Angio GJ; Evans AE
    J Pediatr Surg; 1992 Nov; 27(11):1438-41. PubMed ID: 1479507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution.
    August CS; Serota FT; Koch PA; Burkey E; Schlesinger H; Elkins WL; Evans AE; D'Angio GJ
    J Clin Oncol; 1984 Jun; 2(6):609-16. PubMed ID: 6374056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant.
    von Allmen D; Grupp S; Diller L; Marcus K; Ecklund K; Meyer J; Shamberger RC
    J Pediatr Surg; 2005 Jun; 40(6):936-41; discussion 941. PubMed ID: 15991174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group.
    Garaventa A; Rondelli R; Lanino E; Dallorso S; Dini G; Bonetti F; Arrighini A; Santoro N; Rossetti F; Miniero R; Andolina M; Amici A; Indolfi P; Lo Curto M; Favre C; Paolucci P; Pession A; De Bernardi B
    Bone Marrow Transplant; 1996 Jul; 18(1):125-30. PubMed ID: 8832005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relapsed stage I neuroblastoma successfully treated by allogeneic bone marrow transplantation in second remission: case report of a 7-year-old girl].
    Hanada R; Yaginuma A; Hayashi Y; Inaba T; Yamamoto K; Imaizumi S; Hirata A; Sugawara T; Aihara T; Miyakawa T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1937-9. PubMed ID: 2203317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Massive chemotherapy and purged bone marrow autograft in severe neuroblastoma. Preliminary results apropos of 5 cases].
    Frappaz D; Philip T; Philip I; Biron P; Bouffet E; Favrot M; Veley B; Martinez MF; Lacroze M; Dutou L
    Pediatrie; 1985; 40(7):539-51. PubMed ID: 3913896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
    Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
    Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.